BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SUBLOCADE (buprenorphine extended-release) readouts · AssetMe
 mo
X-WR-CALDESC:Upcoming readouts of SUBLOCADE (buprenorphine extended-release
 )\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06880718-10944@assetmemo.bio
DTSTAMP:20261121T005710Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:SUBLOCADE (buprenorphine extended-release): Phase 4 readout est. (N
 CT06880718)
DESCRIPTION:SUBLOCADE (buprenorphine extended-release)\, phase 4\, Opioid U
 se Disorder.\nStudy: Injectable Buprenorphine in Prison: A Preference Tria
 l\nEstimated primary completion: January 2027. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/buprenorphine-extended-release#upcoming-events\n
 Registry record: https://clinicaltrials.gov/study/NCT06880718
URL:https://assetmemo.bio/drug/buprenorphine-extended-release#upcoming-even
 ts
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
